IL17RA and arthritic joint disease: In this study, we addressed the contribution of IL-17RA signaling to the effector phase of arthritis in the K/BxN serum transfer model by subjecting Il17ra−/− mice to serum transfer and found that IL-17RA deficiency attenuated the severity of serum-induced arthritis.